Skip to results

Keyword or reference number

Keyword or reference number

Type

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 376 to 389 of 389

Guidance and quality standards awaiting development
TitleType
Vosoritide for treating achondroplasia in children and young people under 18 years [ID3807]Technology appraisal guidance
Vulnerable populations: strategies for tackling inequalitiesQuality standard
VX-522 for treating cystic fibrosis unresponsive to CFTR modulators when there are 2 mutations in the CFTR gene [TSID12431]Technology appraisal guidance
WP1048 for treating grass pollen allergy in people aged 18 to 60 [TSID10467]Technology appraisal guidance
Xeomin (botulinum neurotoxin type A) for treating lower limb spasticity [TSID11902]Technology appraisal guidance
Zamtocabtagene autoleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more therapies [TSID10765]Technology appraisal guidance
Zamtocabtagene autoleucel for treating relapsed or refractory diffuse large B-cell lymphoma when high-dose chemotherapy and autologous stem cell transplant are unsuitable [TSID10477]Technology appraisal guidance
Zanubrutinib with rituximab for untreated mantle cell lymphoma when a stem cell transplant is unsuitable [ID6641]Technology appraisal guidance
Zasocitinib for treating moderate to severe plaque psoriasis [ID6700]Technology appraisal guidance
Zavegepant for treating acute migraine [TSID11998]Technology appraisal guidance
Zibotentan–dapagliflozin for treating chronic kidney disease with proteinuria [TSID12423]Technology appraisal guidance
Zilurgisertib for preventing new heterotopic ossification lesions caused by fibrodysplasia ossificans progressiva in people 12 years and over [ID6637]Technology appraisal guidance
Zimislecel for treating type 1 diabetes in people 12 years and over with impaired hypoglycaemic awareness and severe hypoglycaemia [ID6624]Technology appraisal guidance
Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [TSID12040]Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All